Ji Yeong Kim
Seoul, South Korea
NCT Number: NCT05212038
Nielsen et al. reported that when iliopsoas plane block was performed on healthy volunteers, the injection solution in Hip MRI was confined to the myofascial compartment, which was known to include all sensory branches of the femoral nerve that control the hip joint. The maximal muscle strength of knee extension did not decrease before and after Iliopsoas plane block in Volunteer. Since there is no clinical study conducted on patients after the volunteer study, the investigators intend to evaluate the analgesic and motor preserving effects of the iliopsoas plane block in a group of patients undergoing total hip arthroplasty.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Seoul, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound-guided iliopsoas plane block with 0.75% ropivacaine 10 ml and epinephrine 0.05 ml (1:200,000) 10 ml
Ultrasound-guided iliopsoas plane block with normal saline 10 ml
Time frame: up to 48 hours after the surgery
Pain intensity at rest will be evaluated by an 11-point numeric rating scale (NRS: 0 = no pain, 10 = worst imaginable pain) 1, 6, 24, and 48 hours after the surgery.
Time frame: up to 48 hours postoperatively
Pain intensity during 45-degree passive flexion of the hip with the ipsilateral knee flexed naturally will be evaluated by an 11-point numeric rating scale (NRS: 0 = no pain, 10 = worst imaginable pain) 1, 6, 24, and 48 hours after the surgery.
Time frame: postoperative 24, 48hours
morphine equivalent dose
Gangnam Severance Hospital
Other
An Iliopsoas Plane Block for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05530551
Arthritis, Joint Diseases
Aabenraa, Denmark
View Trial DetailsNCT03789266
Drain Insertion Site, Total Hip Arthroplasty
Rouen, France
View Trial DetailsNCT07610863
Coagulation Monitoring Using ROTEM, Perioperative Blood Loss
Brno, Czechia
View Trial DetailsNCT06577155
Agnosia, Analgesia
Athens, Ελλάδα (+30), Greece
View Trial Details